CSAM Health Wins National Agreement for Danish eHealth Blood Bank Solution

CSAMCSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, announced it has signed a contract with the five regions within the Danish health authority for CSAM’s Prosang blood, cell, and tissue management system for blood banks. In an agreement between CSAM and all five health regions, the new contract will translate to approximately NOK 75-100 million NOK over at the next six years and will be implemented in all blood banks in the country.

Until today, the CSAM Prosang solution was rolled out in four of five Danish regions: Mid Jylland, North Jylland, South Denmark and Sjælland. The new nation-wide contract, including the country's fifth region, Region Hovedstaden (Capital Region), secures CSAM’s position as niche provider of blood bank management services for national health providers across the country.

"We are pleased to enter this new agreement with CSAM Health Group, that essentially enables the Danish health regions to provide a nationwide, consolidated solution for blood bank management services," says Kim Brixen, Chairman of the Steering Group.

"All current CSAM Prosang installations in Denmark, in addition to the new installation in the Copenhagen region will be migrated into a national service supporting data quality, security, information sharing, workflow support and integrations.

"The new e-health solutions agreement reconfirms CSAM's sustainability, adding another national market win and further enhancing its strong Nordic leadership within niche e-health solutions.

"In December 2019, CSAM reached 100% market share in Sweden within the blood bank management segment when we signed an agreement with Region Skåne," says Daniel Wiman, Product Manager at CSAM.

"Four of the five Danish regions have been using the CSAM ProSang solution for several years in separate installations throughout the country. Thus, we are very excited that now all health regions have selected ProSang as their common platform and preferred national blood bank management program for blood, cells, and tissues," continues Wiman.

According to CSAM, the complete Danish national installation will service thousands of regular users, manage over 300.000 blood donations, several hundred transplants, and approximately 700.000 examinations every year.

About CSAM Prosang

CSAM ProSang, Scandinavia's leading blood, cell, and tissue management system, is an advanced Laboratory Information Management System (LIMS) that simplifies the entire management of blood, cells and tissues - from donation to transfusion or transplantation. Today, Prosang is employed in five countries and operational at over 180 blood centres in 27 healthcare regions.

CSAM's benchmark bouquet of benchmark eHealth solutions

CSAM's strategy is to gather the best e-health software services solutions on the market into one unique family to provide a complete portfolio of benchmark. CSAM is harnessing best-of-breed technology and solutions to empower its customers to do what they do best.

For further information, please visit:
http://www.csamhealth.com

About CSAM

CSAM has established itself as a leading Nordic niche player in the specialised eHealth market with a unique blend of best-in-class innovative technology, and outstanding human skills. The company's diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. CSAM's commercial headquarters are located in Oslo, Norway. In addition, CSAM has 17 local offices in 10 countries in Europe, Asia and North America.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...